New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients Notified - ---
M/Y Dagger joins the SEA Index®: HSH Prince Albert II discovers Benetti’s new hybrid yacht Notified -
Hummingbird Bioscience Announces First Patient Dosed in Phase II Trial of HMBD-001 and Cetuximab in Advanced Squamous Cell Cancers Notified -
A New Chapter for German Aviation: Deutsche Aircraft Opens D328eco® Final Assembly Line in Leipzig Notified -
TekniPlex Healthcare to Showcase Wearable Drug Delivery, Ophthalmic Innovations, and Pharmaceutical Protection at CPHI Milan 2026 Notified -
TestMu AI Brings iPhone 18 Pro and iPhone 18 Pro Max to Its Real Device Cloud Within Days of Apple's Launch Notified -
Morae Launches MorAI Legal Intelligence Platform with Spend Module Combining AI and Human Review Notified -
TMC Announces Appointment of Liam Mallon, Former President of ExxonMobil Upstream, to its Board of Directors Notified -
Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million Notified -
ProductLife Group completes its transformation into a single, unified group with an end-to-end set of human and digital capabilities across life sciences Notified -